FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Parasit Vectors / Ivermectin-induced gene expression changes in adult Parascar...
Parasites & vectors2022; 15(1); 158; doi: 10.1186/s13071-022-05260-4

Ivermectin-induced gene expression changes in adult Parascaris univalens and Caenorhabditis elegans: a comparative approach to study anthelminthic metabolism and resistance in vitro.

Abstract: The nematode Parascaris univalens is one of the most prevalent parasitic pathogens infecting horses but anthelmintic resistance undermines treatment approaches. The molecular mechanisms underlying drug activity and resistance remain poorly understood in this parasite since experimental in vitro models are lacking. The aim of this study was to evaluate the use of Caenorhabditis elegans as a model for P. univalens drug metabolism/resistance studies by a comparative gene expression approach after in vitro exposure to the anthelmintic drug ivermectin (IVM). Methods: Twelve adult P. univalens worms in groups of three were exposed to ivermectin (IVM, 10 M, 10 M, 10 M) or left unexposed for 24 h at 37 °C, and total RNA, extracted from the anterior end of the worms, was sequenced using Illumina NovaSeq. Differentially expressed genes (DEGs) involved in metabolism, transportation, or gene expression with annotated Caernorhabditis elegans orthologues were identified as candidate genes to be involved in IVM metabolism/resistance. Similarly, groups of 300 adult C. elegans worms were exposed to IVM (10 M, 10 M and 10 M) or left unexposed for 4 h at 20 °C. Quantitative RT-PCR of RNA extracted from the C. elegans worm pools was used to compare against the expression of selected P. univalens candidate genes after drug treatment. Results: After IVM exposure, 1085 DEGs were found in adult P. univalens worms but the relative gene expression changes were small and large variabilities were found between different worms. Fifteen of the DEGs were chosen for further characterization in C. elegans after comparative bioinformatics analyses. Candidate genes, including the putative drug target lgc-37, responded to IVM in P. univalens, but marginal to no responses were observed in C. elegans despite dose-dependent behavioral effects observed in C. elegans after IVM exposure. Thus, the overlap in IVM-induced gene expression in this small set of genes was minor in adult worms of the two nematode species. Conclusions: This is the first time to our knowledge that a comparative gene expression approach has evaluated C. elegans as a model to understand IVM metabolism/resistance in P. univalens. Genes in P. univalens adults that responded to IVM treatment were identified. However, identifying conserved genes in P. univalens and C. elegans involved in IVM metabolism/resistance by comparing gene expression of candidate genes proved challenging. The approach appears promising but was limited by the number of genes studied (n = 15). Future studies comparing a larger number of genes between the two species may result in identification of additional candidate genes involved in drug metabolism and/or resistance.
© 2022. The Author(s).
Get Full Text
Publication Date: 2022-05-05 PubMed ID: 35513885PubMed Central: PMC9074254DOI: 10.1186/s13071-022-05260-4Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study explores the molecular mechanisms of ivermectin (an anti-parasitic drug) metabolism and resistance in Parascaris univalens, a common parasitic worm infecting horses. The study compares gene expression changes induced by ivermectin in P. univalens and Caenorhabditis elegans, a model organism often used in biological research.

Research Objectives and Methodology

The researchers aimed to understand how ivermectin affects P. univalens and whether C. elegans can serve as an appropriate model for studying ivermectin treatment in P. univalens. They used comparative gene expression techniques post-exposure to ivermectin in both worms.

  • P. univalens and C. elegans worms underwent exposure to different ivermectin concentrations for 24 hours and 4 hours at respective temperatures of 37°C and 20°C.
  • Total RNA was then extracted and sequenced to identify differentially expressed genes (DEGs).
  • Particular attention was given to DEGs involved in metabolism, transport, or gene expression which had annotated C. elegans orthologues (equivalent genes).
  • Quantitative reverse transcriptase–polymerase chain reaction (RT-qPCR) was performed on RNA from C. elegans to compare the expression of selected genes to their counterparts in P. univalens after ivermectin exposure.

Results

Following ivermectin treatment, the researchers identified 1085 DEGs in P. univalens. However, the gene expression changes were minor, and considerable variability was observed between different worm samples. After some comparative bioinformatics analysis, 15 of these DEGs were selected for further characterization in C. elegans.

  • These candidate genes, including the putative drug target lgc-37, demonstrated response to ivermectin in P. univalens, but little to no response in C. elegans, despite the drug causing dose-dependent behavioral effects in the latter.
  • The researchers hence concluded that the overlap in ivermectin-induced gene expression changes between P. univalens and C. elegans was minor.

Conclusions and Future Directions

This study was the first to use a comparative gene expression approach to assess if C. elegans can serve as a model for understanding ivermectin metabolism/resistance in P. univalens. While the scientists identified P. univalens genes that responded to ivermectin treatment, finding conserved genes in both P. univalens and C. elegans proved challenging.

  • The research showed potential but was limited by the number of genes studied.
  • The authors suggested that future investigations comparing more genes between the two worm species may result in the identification of more candidate genes involved in drug metabolism and resistance.

Cite This Article

APA
Dube F, Hinas A, Roy S, Martin F, Åbrink M, Svärd S, Tydén E. (2022). Ivermectin-induced gene expression changes in adult Parascaris univalens and Caenorhabditis elegans: a comparative approach to study anthelminthic metabolism and resistance in vitro. Parasit Vectors, 15(1), 158. https://doi.org/10.1186/s13071-022-05260-4

Publication

Parasites & vectors
ISSN: 1756-3305
NlmUniqueID: 101462774
Country: England
Language: English
Volume: 15
Issue: 1
Pages: 158
PII: 158

Researcher Affiliations

Dube, Faruk
  • Division of Parasitology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Box 7036, 750 07, Uppsala, Sweden. faruk.dube@slu.se.
Hinas, Andrea
  • Department of Cell and Molecular Biology, Uppsala University, 751 24, Uppsala, Sweden.
Roy, Shweta
  • Department of Cell and Molecular Biology, Uppsala University, 751 24, Uppsala, Sweden.
Martin, Frida
  • Division of Parasitology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Box 7036, 750 07, Uppsala, Sweden.
Åbrink, Magnus
  • Section of Immunology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Box 7036, 750 07, Uppsala, Sweden.
Svärd, Staffan
  • Department of Cell and Molecular Biology, Uppsala University, 751 24, Uppsala, Sweden.
Tydén, Eva
  • Division of Parasitology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Box 7036, 750 07, Uppsala, Sweden.

MeSH Terms

  • Animals
  • Anthelmintics / therapeutic use
  • Ascaridoidea
  • Caenorhabditis elegans
  • Drug Resistance / genetics
  • Gene Expression
  • Horses
  • Ivermectin / therapeutic use
  • RNA / metabolism

Grant Funding

  • 2018-01049 / Svenska Forskningsru00e5det Formas

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 81 references
  1. Laugier C, Sevin C, Ménard S, Maillard K. Prevalence of Parascaris equorum infection in foals on French stud farms and first report of ivermectin-resistant P. equorum populations in France.. Vet Parasitol 2012 Aug 13;188(1-2):185-9.
    doi: 10.1016/j.vetpar.2012.02.022pubmed: 22494940google scholar: lookup
  2. Relf VE, Morgan ER, Hodgkinson JE, Matthews JB. Helminth egg excretion with regard to age, gender and management practices on UK Thoroughbred studs.. Parasitology 2013 Apr;140(5):641-52.
    doi: 10.1017/S0031182012001941pubmed: 23351718google scholar: lookup
  3. Armstrong SK, Woodgate RG, Gough S, Heller J, Sangster NC, Hughes KJ. The efficacy of ivermectin, pyrantel and fenbendazole against Parascaris equorum infection in foals on farms in Australia.. Vet Parasitol 2014 Oct 15;205(3-4):575-80.
    doi: 10.1016/j.vetpar.2014.08.028pubmed: 25224788google scholar: lookup
  4. Alanazi AD, Mukbel RM, Alyousif MS, AlShehri ZS, Alanazi IO, Al-Mohammed HI. A field study on the anthelmintic resistance of Parascaris spp. in Arab foals in the Riyadh region, Saudi Arabia.. Vet Q 2017 Dec;37(1):200-205.
    doi: 10.1080/01652176.2017.1334981pubmed: 28537782google scholar: lookup
  5. Cribb NC, Cote NM, Bouré LP, Peregrine AS. Acute small intestinal obstruction associated with Parascaris equorum infection in young horses: 25 cases (1985-2004).. N Z Vet J 2006 Dec;54(6):338-43.
    doi: 10.1080/00480169.2006.36721pubmed: 17151735google scholar: lookup
  6. Clayton HM, Duncan JL. The migration and development of Parascaris equorum in the horse.. Int J Parasitol 1979 Aug;9(4):285-92.
    doi: 10.1016/0020-7519(79)90076-6pubmed: 489235google scholar: lookup
  7. Clayton HM. Ascarids. Recent advances.. Vet Clin North Am Equine Pract 1986 Aug;2(2):313-28.
    doi: 10.1016/S0749-0739(17)30718-6pubmed: 3527375google scholar: lookup
  8. Nielsen MK. Evidence-based considerations for control of Parascaris spp. infections in horses.. Equine Vet Educ 2016;28:224–231.
    doi: 10.1111/eve.12536google scholar: lookup
  9. Shoop WL, Mrozik H, Fisher MH. Structure and activity of avermectins and milbemycins in animal health.. Vet Parasitol 1995 Sep;59(2):139-56.
    doi: 10.1016/0304-4017(94)00743-Vpubmed: 7483237google scholar: lookup
  10. Wolstenholme AJ, Rogers AT. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics.. Parasitology 2005;131 Suppl:S85-95.
    doi: 10.1017/S0031182005008218pubmed: 16569295google scholar: lookup
  11. Reinemeyer CR. Diagnosis and control of anthelmintic-resistant Parascaris equorum.. Parasit Vectors 2009 Sep 25;2 Suppl 2(Suppl 2):S8.
    doi: 10.1186/1756-3305-2-S2-S8pmc: PMC2751844pubmed: 19778469google scholar: lookup
  12. Cooper LG, Caffe G, Cerutti J, Nielsen MK, Anziani OS. Reduced efficacy of ivermectin and moxidectin against Parascaris spp. in foals from Argentina.. Vet Parasitol Reg Stud Reports 2020 Apr;20:100388.
    pubmed: 32448542doi: 10.1016/j.vprsr.2020.100388google scholar: lookup
  13. Lindgren K, Ljungvall O, Nilsson O, Ljungström BL, Lindahl C, Höglund J. Parascaris equorum in foals and in their environment on a Swedish stud farm, with notes on treatment failure of ivermectin.. Vet Parasitol 2008 Feb 14;151(2-4):337-43.
    doi: 10.1016/j.vetpar.2007.10.014pubmed: 18077096google scholar: lookup
  14. Martin F, Svansson V, Eydal M, Oddsdóttir C, Ernback M, Persson I, Tydén E. First Report of Resistance to Ivermectin in Parascaris univalens in Iceland.. J Parasitol 2021 Jan 1;107(1):16-22.
    doi: 10.1645/20-91pubmed: 33498083google scholar: lookup
  15. Whittaker JH, Carlson SA, Jones DE, Brewer MT. Molecular mechanisms for anthelmintic resistance in strongyle nematode parasites of veterinary importance.. J Vet Pharmacol Ther 2017 Apr;40(2):105-115.
    doi: 10.1111/jvp.12330pubmed: 27302747google scholar: lookup
  16. James CE, Hudson AL, Davey MW. Drug resistance mechanisms in helminths: is it survival of the fittest?. Trends Parasitol 2009 Jul;25(7):328-35.
    doi: 10.1016/j.pt.2009.04.004pubmed: 19541539google scholar: lookup
  17. Njue AI, Hayashi J, Kinne L, Feng XP, Prichard RK. Mutations in the extracellular domains of glutamate-gated chloride channel alpha3 and beta subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity.. J Neurochem 2004 Jun;89(5):1137-47.
    doi: 10.1111/j.1471-4159.2004.02379.xpubmed: 15147506google scholar: lookup
  18. McCavera S, Rogers AT, Yates DM, Woods DJ, Wolstenholme AJ. An ivermectin-sensitive glutamate-gated chloride channel from the parasitic nematode Haemonchus contortus.. Mol Pharmacol 2009 Jun;75(6):1347-55.
    doi: 10.1124/mol.108.053363pmc: PMC2684884pubmed: 19336526google scholar: lookup
  19. El-Abdellati A, De Graef J, Van Zeveren A, Donnan A, Skuce P, Walsh T, Wolstenholme A, Tait A, Vercruysse J, Claerebout E, Geldhof P. Altered avr-14B gene transcription patterns in ivermectin-resistant isolates of the cattle parasites, Cooperia oncophora and Ostertagia ostertagi.. Int J Parasitol 2011 Aug 1;41(9):951-7.
    doi: 10.1016/j.ijpara.2011.04.003pubmed: 21683704google scholar: lookup
  20. Williamson SM, Storey B, Howell S, Harper KM, Kaplan RM, Wolstenholme AJ. Candidate anthelmintic resistance-associated gene expression and sequence polymorphisms in a triple-resistant field isolate of Haemonchus contortus.. Mol Biochem Parasitol 2011 Dec;180(2):99-105.
    doi: 10.1016/j.molbiopara.2011.09.003pubmed: 21945142google scholar: lookup
  21. Dicker AJ, Nisbet AJ, Skuce PJ. Gene expression changes in a P-glycoprotein (Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia circumcincta.. Int J Parasitol 2011 Aug 1;41(9):935-42.
    doi: 10.1016/j.ijpara.2011.03.015pubmed: 21683705google scholar: lookup
  22. Raza A, Kopp SR, Bagnall NH, Jabbar A, Kotze AC. Effects of in vitro exposure to ivermectin and levamisole on the expression patterns of ABC transporters in Haemonchus contortus larvae.. Int J Parasitol Drugs Drug Resist 2016 Aug;6(2):103-15.
    doi: 10.1016/j.ijpddr.2016.03.001pmc: PMC4919253pubmed: 27164439google scholar: lookup
  23. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.. Adv Drug Deliv Rev 2003 Jan 21;55(1):3-29.
    doi: 10.1016/S0169-409X(02)00169-2pubmed: 12535572google scholar: lookup
  24. Xu M, Molento M, Blackhall W, Ribeiro P, Beech R, Prichard R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog.. Mol Biochem Parasitol 1998 Mar 15;91(2):327-35.
    doi: 10.1016/S0166-6851(97)00215-6pubmed: 9566525google scholar: lookup
  25. Matoušková P, Vokřál I, Lamka J, Skálová L. The Role of Xenobiotic-Metabolizing Enzymes in Anthelmintic Deactivation and Resistance in Helminths.. Trends Parasitol 2016 Jun;32(6):481-491.
    doi: 10.1016/j.pt.2016.02.004pubmed: 26968642google scholar: lookup
  26. Yilmaz E, Ramünke S, Demeler J, Krücken J. Comparison of constitutive and thiabendazole-induced expression of five cytochrome P450 genes in fourth-stage larvae of Haemonchus contortus isolates with different drug susceptibility identifies one gene with high constitutive expression in a multi-resistant isolate.. Int J Parasitol Drugs Drug Resist 2017 Dec;7(3):362-369.
    doi: 10.1016/j.ijpddr.2017.10.001pmc: PMC5645160pubmed: 29035734google scholar: lookup
  27. Matoušková P, Lecová L, Laing R, Dimunová D, Vogel H, Raisová Stuchlíková L, Nguyen LT, Kellerová P, Vokřál I, Lamka J, Szotáková B, Várady M, Skálová L. UDP-glycosyltransferase family in Haemonchus contortus: Phylogenetic analysis, constitutive expression, sex-differences and resistance-related differences.. Int J Parasitol Drugs Drug Resist 2018 Dec;8(3):420-429.
    doi: 10.1016/j.ijpddr.2018.09.005pmc: PMC6174829pubmed: 30293057google scholar: lookup
  28. Janssen IJ, Krücken J, Demeler J, Basiaga M, Kornaś S, von Samson-Himmelstjerna G. Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility.. PLoS One 2013;8(4):e61635.
    doi: 10.1371/journal.pone.0061635pmc: PMC3634834pubmed: 23637871google scholar: lookup
  29. Martin F, Dube F, Karlsson Lindsjö O, Eydal M, Höglund J, Bergström TF, Tydén E. Transcriptional responses in Parascaris univalens after in vitro exposure to ivermectin, pyrantel citrate and thiabendazole.. Parasit Vectors 2020 Jul 9;13(1):342.
    doi: 10.1186/s13071-020-04212-0pmc: PMC7346371pubmed: 32646465google scholar: lookup
  30. Scare JA, Dini P, Norris JK, Steuer AE, Scoggin K, Gravatte HS, Howe DK, Slusarewicz P, Nielsen MK. Ascarids exposed: a method for in vitro drug exposure and gene expression analysis of anthelmintic naïve Parascaris spp.. Parasitology 2020 May;147(6):659-666.
    doi: 10.1017/S0031182020000189pubmed: 32046800google scholar: lookup
  31. Martin F, Eydal M, Höglund J, Tydén E. Constitutive and differential expression of transport protein genes in Parascaris univalens larvae and adult tissues after in vitro exposure to anthelmintic drugs.. Vet Parasitol 2021 Oct;298:109535.
    doi: 10.1016/j.vetpar.2021.109535pubmed: 34340009google scholar: lookup
  32. Gibson SB, Harper CS, Lackner LL, Andersen EC. The Caenorhabditis elegans and Haemonchus contortus beta-tubulin genes cannot substitute for loss of the Saccharomyces cerevisiae beta-tubulin gene.. MicroPubl Biol 2021 Jun 30;2021.
    doi: 10.17912/micropub.biology.000411pmc: PMC8246273pubmed: 34222836google scholar: lookup
  33. Ondua M, Mfotie Njoya E, Abdalla MA, McGaw LJ. Investigation of anthelmintic activity of the acetone extract and constituents of Typha capensis against animal parasitic Haemonchus contortus and free-living Caenorhabditis elegans.. Parasitol Res 2021 Oct;120(10):3437-3449.
    doi: 10.1007/s00436-021-07269-7pubmed: 34424423google scholar: lookup
  34. Yates DM, Portillo V, Wolstenholme AJ. The avermectin receptors of Haemonchus contortus and Caenorhabditis elegans.. Int J Parasitol 2003 Sep 30;33(11):1183-93.
    doi: 10.1016/S0020-7519(03)00172-3pubmed: 13678634google scholar: lookup
  35. Stasiuk SJ, MacNevin G, Workentine ML, Gray D, Redman E, Bartley D, Morrison A, Sharma N, Colwell D, Ro DK, Gilleard JS. Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs.. Int J Parasitol Drugs Drug Resist 2019 Dec;11:13-29.
    doi: 10.1016/j.ijpddr.2019.09.001pmc: PMC6796749pubmed: 31542693google scholar: lookup
  36. Gerhard AP, Krücken J, Neveu C, Charvet CL, Harmache A, von Samson-Himmelstjerna G. Pharyngeal Pumping and Tissue-Specific Transgenic P-Glycoprotein Expression Influence Macrocyclic Lactone Susceptibility in Caenorhabditis elegans.. Pharmaceuticals (Basel) 2021 Feb 13;14(2).
    doi: 10.3390/ph14020153pmc: PMC7917992pubmed: 33668460google scholar: lookup
  37. Janssen IJ, Krücken J, Demeler J, von Samson-Himmelstjerna G. Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans.. Int J Parasitol Drugs Drug Resist 2015 Aug;5(2):44-7.
    doi: 10.1016/j.ijpddr.2015.03.003pmc: PMC4401813pubmed: 25905032google scholar: lookup
  38. Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LH, Schaeffer JM, Arena JP. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans.. Nature 1994 Oct 20;371(6499):707-11.
    doi: 10.1038/371707a0pubmed: 7935817google scholar: lookup
  39. Dent JA, Smith MM, Vassilatis DK, Avery L. The genetics of ivermectin resistance in Caenorhabditis elegans.. Proc Natl Acad Sci U S A 2000 Mar 14;97(6):2674-9.
    doi: 10.1073/pnas.97.6.2674pmc: PMC15988pubmed: 10716995google scholar: lookup
  40. Gilleard JS. The use of Caenorhabditis elegans in parasitic nematode research.. Parasitology 2004;128 Suppl 1:S49-70.
    doi: 10.1017/S003118200400647Xpubmed: 16454899google scholar: lookup
  41. Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor.. Bioinformatics 2018 Sep 1;34(17):i884-i890.
    doi: 10.1093/bioinformatics/bty560pmc: PMC6129281pubmed: 30423086google scholar: lookup
  42. Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression.. Nat Methods 2017 Apr;14(4):417-419.
    doi: 10.1038/nmeth.4197pmc: PMC5600148pubmed: 28263959google scholar: lookup
  43. Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.. F1000Res 2015;4:1521.
    doi: 10.12688/f1000research.7563.1pmc: PMC4712774pubmed: 26925227google scholar: lookup
  44. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.. J R Stat Soc Ser B (Methodol) 1995;57:289–300.
  45. Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R.. BMC Bioinformatics 2011 Jan 26;12:35.
    doi: 10.1186/1471-2105-12-35pmc: PMC3041657pubmed: 21269502google scholar: lookup
  46. Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction.. Nat Methods 2015 Jan;12(1):7-8.
    doi: 10.1038/nmeth.3213pmc: PMC4428668pubmed: 25549265google scholar: lookup
  47. Brenner S. The genetics of Caenorhabditis elegans.. Genetics 1974 May;77(1):71-94.
    doi: 10.1093/genetics/77.1.71pmc: PMC1213120pubmed: 4366476google scholar: lookup
  48. Stiernagle T. Maintenance of C. elegans.. WormBook 2006 Feb 11;:1-11.
    pmc: PMC4781397pubmed: 18050451doi: 10.1895/wormbook.1.101.1google scholar: lookup
  49. Porta-de-la-Riva M, Fontrodona L, Villanueva A, Cerón J. Basic Caenorhabditis elegans methods: synchronization and observation.. J Vis Exp 2012 Jun 10;(64):e4019.
    pmc: PMC3607348pubmed: 22710399doi: 10.3791/4019google scholar: lookup
  50. Johnson JR, Ferdek P, Lian LY, Barclay JW, Burgoyne RD, Morgan A. Binding of UNC-18 to the N-terminus of syntaxin is essential for neurotransmission in Caenorhabditis elegans.. Biochem J 2009 Feb 15;418(1):73-80.
    doi: 10.1042/BJ20081956pubmed: 19032153google scholar: lookup
  51. Howe KL, Bolt BJ, Shafie M, Kersey P, Berriman M. WormBase ParaSite - a comprehensive resource for helminth genomics.. Mol Biochem Parasitol 2017 Jul;215:2-10.
    doi: 10.1016/j.molbiopara.2016.11.005pmc: PMC5486357pubmed: 27899279google scholar: lookup
  52. Chen N, Harris TW, Antoshechkin I, Bastiani C, Bieri T, Blasiar D, Bradnam K, Canaran P, Chan J, Chen CK, Chen WJ, Cunningham F, Davis P, Kenny E, Kishore R, Lawson D, Lee R, Muller HM, Nakamura C, Pai S, Ozersky P, Petcherski A, Rogers A, Sabo A, Schwarz EM, Van Auken K, Wang Q, Durbin R, Spieth J, Sternberg PW, Stein LD. WormBase: a comprehensive data resource for Caenorhabditis biology and genomics.. Nucleic Acids Res 2005 Jan 1;33(Database issue):D383-9.
    doi: 10.1093/nar/gki066pmc: PMC540020pubmed: 15608221google scholar: lookup
  53. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.. Methods 2001 Dec;25(4):402-8.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  54. Martin F, Höglund J, Bergström TF, Karlsson Lindsjö O, Tydén E. Resistance to pyrantel embonate and efficacy of fenbendazole in Parascaris univalens on Swedish stud farms.. Vet Parasitol 2018 Dec 15;264:69-73.
    doi: 10.1016/j.vetpar.2018.11.003pubmed: 30503095google scholar: lookup
  55. Ballesteros C, Tritten L, O'Neill M, Burkman E, Zaky WI, Xia J, Moorhead A, Williams SA, Geary TG. The Effects of Ivermectin on Brugia malayi Females In Vitro: A Transcriptomic Approach.. PLoS Negl Trop Dis 2016 Aug;10(8):e0004929.
    doi: 10.1371/journal.pntd.0004929pmc: PMC4986938pubmed: 27529747google scholar: lookup
  56. Schurch NJ, Schofield P, Gierliński M, Cole C, Sherstnev A, Singh V, Wrobel N, Gharbi K, Simpson GG, Owen-Hughes T, Blaxter M, Barton GJ. How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use?. RNA 2016 Jun;22(6):839-51.
    doi: 10.1261/rna.053959.115pmc: PMC4878611pubmed: 27022035google scholar: lookup
  57. Hahnel SR, Dilks CM, Heisler I, Andersen EC, Kulke D. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.. Int J Parasitol Drugs Drug Resist 2020 Dec;14:237-248.
    doi: 10.1016/j.ijpddr.2020.09.005pmc: PMC7704361pubmed: 33249235google scholar: lookup
  58. Holden-Dye L, Walker RJ. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.. WormBook 2014 Dec 16;:1-29.
    pmc: PMC5402214pubmed: 25517625doi: 10.1895/wormbook.1.143.2google scholar: lookup
  59. Salinas G, Risi G. Caenorhabditis elegans: nature and nurture gift to nematode parasitologists.. Parasitology 2018 Jul;145(8):979-987.
    doi: 10.1017/S0031182017002165pubmed: 29208057google scholar: lookup
  60. Jex AR, Liu S, Li B, Young ND, Hall RS, Li Y, Yang L, Zeng N, Xu X, Xiong Z, Chen F, Wu X, Zhang G, Fang X, Kang Y, Anderson GA, Harris TW, Campbell BE, Vlaminck J, Wang T, Cantacessi C, Schwarz EM, Ranganathan S, Geldhof P, Nejsum P, Sternberg PW, Yang H, Wang J, Wang J, Gasser RB. Ascaris suum draft genome.. Nature 2011 Oct 26;479(7374):529-33.
    doi: 10.1038/nature10553pubmed: 22031327google scholar: lookup
  61. Blaxter ML, De Ley P, Garey JR, Liu LX, Scheldeman P, Vierstraete A, Vanfleteren JR, Mackey LY, Dorris M, Frisse LM, Vida JT, Thomas WK. A molecular evolutionary framework for the phylum Nematoda.. Nature 1998 Mar 5;392(6671):71-5.
    doi: 10.1038/32160pubmed: 9510248google scholar: lookup
  62. . Comparative genomics of the major parasitic worms.. Nat Genet 2019 Jan;51(1):163-174.
    doi: 10.1038/s41588-018-0262-1pmc: PMC6349046pubmed: 30397333google scholar: lookup
  63. Viney M. The genomic basis of nematode parasitism.. Brief Funct Genomics 2018 Jan 1;17(1):8-14.
    doi: 10.1093/bfgp/elx010pmc: PMC5886223pubmed: 28472353google scholar: lookup
  64. Wang J, Gao S, Mostovoy Y, Kang Y, Zagoskin M, Sun Y, Zhang B, White LK, Easton A, Nutman TB, Kwok PY, Hu S, Nielsen MK, Davis RE. Comparative genome analysis of programmed DNA elimination in nematodes.. Genome Res 2017 Dec;27(12):2001-2014.
    doi: 10.1101/gr.225730.117pmc: PMC5741062pubmed: 29118011google scholar: lookup
  65. Feng XP, Hayashi J, Beech RN, Prichard RK. Study of the nematode putative GABA type-A receptor subunits: evidence for modulation by ivermectin.. J Neurochem 2002 Nov;83(4):870-8.
    doi: 10.1046/j.1471-4159.2002.01199.xpubmed: 12421359google scholar: lookup
  66. Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems.. Microbiol Rev 1996 Dec;60(4):575-608.
    doi: 10.1128/mr.60.4.575-608.1996pmc: PMC239457pubmed: 8987357google scholar: lookup
  67. Yan N. Structural advances for the major facilitator superfamily (MFS) transporters.. Trends Biochem Sci 2013 Mar;38(3):151-9.
    doi: 10.1016/j.tibs.2013.01.003pubmed: 23403214google scholar: lookup
  68. Arena JP, Liu KK, Paress PS, Frazier EG, Cully DF, Mrozik H, Schaeffer JM. The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity.. J Parasitol 1995 Apr;81(2):286-94.
    doi: 10.2307/3283936pubmed: 7707209google scholar: lookup
  69. Avery L, Horvitz HR. Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans.. J Exp Zool 1990 Mar;253(3):263-70.
    doi: 10.1002/jez.1402530305pubmed: 2181052google scholar: lookup
  70. Geary TG, Sims SM, Thomas EM, Vanover L, Davis JP, Winterrowd CA, Klein RD, Ho NF, Thompson DP. Haemonchus contortus: ivermectin-induced paralysis of the pharynx.. Exp Parasitol 1993 Aug;77(1):88-96.
    doi: 10.1006/expr.1993.1064pubmed: 8344410google scholar: lookup
  71. Gerhard AP, Krücken J, Heitlinger E, Janssen IJI, Basiaga M, Kornaś S, Beier C, Nielsen MK, Davis RE, Wang J, von Samson-Himmelstjerna G. The P-glycoprotein repertoire of the equine parasitic nematode Parascaris univalens.. Sci Rep 2020 Aug 12;10(1):13586.
    doi: 10.1038/s41598-020-70529-6pmc: PMC7423980pubmed: 32788636google scholar: lookup
  72. De Graef J, Demeler J, Skuce P, Mitreva M, Von Samson-Himmelstjerna G, Vercruysse J, Claerebout E, Geldhof P. Gene expression analysis of ABC transporters in a resistant Cooperia oncophora isolate following in vivo and in vitro exposure to macrocyclic lactones.. Parasitology 2013 Apr;140(4):499-508.
    doi: 10.1017/S0031182012001849pmc: PMC3690601pubmed: 23279803google scholar: lookup
  73. Cvilink V, Szotáková B, Krízová V, Lamka J, Skálová L. Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).. Res Vet Sci 2009 Feb;86(1):49-55.
    doi: 10.1016/j.rvsc.2008.05.006pubmed: 18565554google scholar: lookup
  74. Cvilink V, Szotáková B, Vokrál I, Bártíková H, Lamka J, Skálová L. Liquid chromatography/mass spectrometric identification of benzimidazole anthelminthics metabolites formed ex vivo by Dicrocoelium dendriticum.. Rapid Commun Mass Spectrom 2009 Sep;23(17):2679-84.
    doi: 10.1002/rcm.4170pubmed: 19630029google scholar: lookup
  75. Prchal L, Bártíková H, Bečanová A, Jirásko R, Vokřál I, Stuchlíková L, Skálová L, Kubíček V, Lamka J, Trejtnar F, Szotáková B. Biotransformation of anthelmintics and the activity of drug-metabolizing enzymes in the tapeworm Moniezia expansa.. Parasitology 2015 Apr;142(5):648-59.
    doi: 10.1017/S0031182014001711pubmed: 25373326google scholar: lookup
  76. Solana HD, Rodriguez JA, Lanusse CE. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites.. Parasitol Res 2001 Apr;87(4):275-80.
    doi: 10.1007/PL00008578pubmed: 11355675google scholar: lookup
  77. Stuchlíková LR, Matoušková P, Vokřál I, Lamka J, Szotáková B, Sečkařová A, Dimunová D, Nguyen LT, Várady M, Skálová L. Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites.. Int J Parasitol Drugs Drug Resist 2018 Apr;8(1):50-58.
    doi: 10.1016/j.ijpddr.2018.01.005pmc: PMC6114105pubmed: 29414106google scholar: lookup
  78. Laing ST, Ivens A, Butler V, Ravikumar SP, Laing R, Woods DJ, Gilleard JS. The transcriptional response of Caenorhabditis elegans to Ivermectin exposure identifies novel genes involved in the response to reduced food intake.. PLoS One 2012;7(2):e31367.
    doi: 10.1371/journal.pone.0031367pmc: PMC3279368pubmed: 22348077google scholar: lookup
  79. Jones LM, Rayson SJ, Flemming AJ, Urwin PE. Adaptive and specialised transcriptional responses to xenobiotic stress in Caenorhabditis elegans are regulated by nuclear hormone receptors.. PLoS One 2013;8(7):e69956.
    doi: 10.1371/journal.pone.0069956pmc: PMC3724934pubmed: 23922869google scholar: lookup
  80. Laing ST, Ivens A, Laing R, Ravikumar S, Butler V, Woods DJ, Gilleard JS. Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites.. Biochem J 2010 Dec 15;432(3):505-14.
    doi: 10.1042/BJ20101346pubmed: 20929438google scholar: lookup
  81. Ménez C, Alberich M, Courtot E, Guegnard F, Blanchard A, Aguilaniu H, Lespine A. The transcription factor NHR-8: A new target to increase ivermectin efficacy in nematodes.. PLoS Pathog 2019 Feb;15(2):e1007598.
    doi: 10.1371/journal.ppat.1007598pmc: PMC6391013pubmed: 30759156google scholar: lookup

Citations

This article has been cited 1 times.
  1. Dube F, Hinas A, Delhomme N, Åbrink M, Svärd S, Tydén E. Transcriptomics of ivermectin response in Caenorhabditis elegans: Integrating abamectin quantitative trait loci and comparison to the Ivermectin-exposed DA1316 strain.. PLoS One 2023;18(5):e0285262.
    doi: 10.1371/journal.pone.0285262pubmed: 37141255google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.